Your browser doesn't support javascript.
loading
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.
Bozkurt, Murat Fani; Virgolini, Irene; Balogova, Sona; Beheshti, Mohsen; Rubello, Domenico; Decristoforo, Clemens; Ambrosini, Valentina; Kjaer, Andreas; Delgado-Bolton, Roberto; Kunikowska, Jolanta; Oyen, Wim J G; Chiti, Arturo; Giammarile, Francesco; Sundin, Anders; Fanti, Stefano.
Afiliação
  • Bozkurt MF; Hacettepe University Faculty of Medicine Department of Nuclear Medicine, Ankara, Turkey. fanibozkurt@yahoo.com.
  • Virgolini I; Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • Balogova S; Department of Nuclear Medicine, Comenius University and St. Elisabeth Oncology Institute, Bratislava, Slovakia.
  • Beheshti M; Department of Nuclear Medicine, Tenon Hospital AP-HP & Université Pierre et Marie Curie, Paris, France.
  • Rubello D; PET-CT Center, Department of Nuclear Medicine & Endocrinology, St. Vincent's Hospital, Linz, Austria.
  • Decristoforo C; Department of Nuclear Medicine, Paracelsus Medical University, Salzburg, Austria.
  • Ambrosini V; Department of Nuclear Medicine, PET Center and Medical Physics and Radiology, Santa Maria della Misericordia Hospital, Rovigo, Italy.
  • Kjaer A; Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • Delgado-Bolton R; Department of Experimental, Diagnostic and Specialty Medicine-DIMES, University of Bologna, Bologna, Italy.
  • Kunikowska J; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, National University Hospital & University of Copenhagen, Copenhagen, Denmark.
  • Oyen WJG; Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro Hospital and Centre for Biomedical Research of La Rioja (CIBIR), Logroño, Spain. rbiolton@gmail.com.
  • Chiti A; Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Giammarile F; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
  • Sundin A; Nuclear Medicine Department, Humanitas University, Rozzano, MI, Italy.
  • Fanti S; Nuclear Medicine, University of Lyon, Lyon, France.
Eur J Nucl Med Mol Imaging ; 44(9): 1588-1601, 2017 08.
Article em En | MEDLINE | ID: mdl-28547177
ABSTRACT
PURPOSE &

METHODS:

Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using 68Ga-DOTA-conjugated peptides, as well as 18F-DOPA imaging for various neuroendocrine neoplasms. RESULTS &

CONCLUSION:

The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with 68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Di-Hidroxifenilalanina / Receptores de Somatostatina / Tumores Neuroendócrinos / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Radioisótopos de Gálio / Compostos Heterocíclicos com 1 Anel Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Di-Hidroxifenilalanina / Receptores de Somatostatina / Tumores Neuroendócrinos / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Radioisótopos de Gálio / Compostos Heterocíclicos com 1 Anel Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article